Stock ALPN ALPINE IMMUNE SCIENCES, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Insiders Alpine Immune Sciences, Inc.

Equities

ALPN

US02083G1004

Real-time Estimate Cboe BZX
Other stock markets
 03:25:11 2024-05-03 pm EDT 		5-day change 1st Jan Change
64.6 USD -0.01% Intraday chart for Alpine Immune Sciences, Inc. +0.05% +238.90%
Apr. 17 North American Morning Briefing : Stock Futures -2- DJ
Apr. 16 TD Cowen Downgrades Alpine Immune Sciences to Hold From Buy MT

Insiders

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Alpine Immune Sciences, Inc Appoints U. Martin Fuhs as Chief Accounting Officer and Principal Accounting Officer
CI
Alpine Immune Sciences Insider Sold Shares Worth $28,671,734, According to a Recent SEC Filing
MT
Alpine Immune Sciences Insider Sold Shares Worth $292,222, According to a Recent SEC Filing
MT
Alpine Immune Sciences Insider Sold Shares Worth $1,120,992, According to a Recent SEC Filing
MT
Alpine Immune Sciences Insider Sold Shares Worth $1,137,230, According to a Recent SEC Filing
MT
Alpine Immune Sciences Insider Sold Shares Worth $288,554, According to a Recent SEC Filing
MT
Alpine Immune Sciences, Inc. Announces Appointment of Wolfgang Dummer as Chief Medical Officer
CI
Alpine Immune Sciences Names M. Christina Yi Chief Technology Officer
MT
Alpine Immune Sciences, Inc. Appoints Andrew Sandler, MD as Chief Medical Officer of the Company, Effective August 17, 2022
CI
Alpine Immune Sciences, Inc. Announces Board Changes
CI
Alpine Immune Sciences Appoints Andrew S. Sandler as Chief Medical Officer
CI
Alpine Immune Sciences, Inc. Announces Resignation of Zelanna Goldberg from the Position of Chief Medical Officer
CI
Insider Buy: Alpine Immune Sciences
MT
Insider Buy: Alpine Immune Sciences
MT
Insider Sell: Alpine Immune Sciences
MT
Insider Sell: Alpine Immune Sciences
MT
Alpine Immune Sciences Appoints Zelanna Goldberg, M.D., M.A.S. as Chief Medical Officer
CI
Alpine Immune Sciences, Inc. Announces Executive Changes
CI
Alpine Immune Sciences Appoints Natasha A. Hernday to its Board of Directors
CI
Alpine Immune Sciences, Inc. Appoints Wayne Gombotz as Chief Technology Officer
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. ALPN Stock
  4. News Alpine Immune Sciences, Inc.
  5. Insiders